Cosstello MR, Meropol NJ, Denlinger CS, Engstrom PF, Wright JJ, Li T, McLaughlin S, Beard M, Cimildoro R: A phase II trial of the proteasome inhibitor bortezomib in patients with recurrent or metastatic adenocarcinoma of the bile duct or gallbladder (NCI #6135). Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post Meeting Edition). 27 (155): e15605,2009.
Current Recommendations for Screening for Cervical Cancer Temple University Hospital Morning Conference Series : 2006.
Treatment of Thromboembolic Disease in Oncological Patients Temple University Hospital Morning Conference Series : 2005.
Methicillin Resistant Staph Aureus Infection in a 26 year old patient Temple University Hospital Morning Conference Series : 2005.